INTERVIEW: Hong Kong Life Sci Investor On De-Risking China
This article was originally published in Clinica
Executive Summary
Foreign investment in Asia’s life science companies is commonplace, but investment groups operating outside the region are often viewed as being less sophisticated or liable to put their money into areas where others fear to tread.